Literature DB >> 30968402

The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.

Citadel J Cabasag1, Melina Arnold1, John Butler2,3, Manami Inoue4, Britton Trabert5, Penelope M Webb6,7, Freddie Bray1, Isabelle Soerjomataram1.   

Abstract

Ovarian cancer is the eighth most common cancer in women worldwide and incidence rates vary markedly by world region. Our study provides a comprehensive overview of ovarian cancer incidence trends globally, examining the influence of birth cohort and period of diagnosis on changing risk. We presented current patterns and trends of ovarian cancer incidence until 2012 using data from successive volumes of Cancer Incidence in Five Contents. The incidence of ovarian cancer is highest in northern and eastern European countries and in northern America. Declining trends were observed in most countries with the exception of a few central and eastern Asian countries. Marked declines were seen in Europe and North America for women aged 50-74 where rates have declined up to 2.4% (95% CI: -3.9, -0.9) annually in Denmark (DNK) over the last decade. Additionally, declines in the incidence rate ratio (IRR) were observed for generations born after the 1930s, with an additional strong period effect seen around 2000 in United States and DNK. In contrast, IRRs increased among younger generations born after the 1950s in Japan and Belarus. Overall, the favorable trends in ovarian cancer incidence is likely due to the increase use of oral contraceptive pills, and changes in the prevalence of other reproductive risk and protective factors for ovarian cancer over the years studied. Changes in disease classifications and cancer registry practices may also partially contribute to the variation in ovarian cancer incidence rates. Thus, continuous cancer surveillance is essential to detect the shifting patterns of ovarian cancer.
© 2019 International Agency for Research on Cancer (IARC/WHO); licensed by UICC.

Entities:  

Keywords:  age-period-cohort; global incidence trends; ovarian cancer

Mesh:

Substances:

Year:  2019        PMID: 30968402      PMCID: PMC6786921          DOI: 10.1002/ijc.32322

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  38 in total

1.  Models for temporal variation in cancer rates. II: Age-period-cohort models.

Authors:  D Clayton; E Schifflers
Journal:  Stat Med       Date:  1987-06       Impact factor: 2.373

Review 2.  Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?

Authors:  Daniel Martin Klotz; Pauline Wimberger
Journal:  Arch Gynecol Obstet       Date:  2017-09-23       Impact factor: 2.344

3.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

4.  Relationship between westernization of dietary habits and mortality from breast and ovarian cancers in Japan.

Authors:  I Kato; S Tominaga; T Kuroishi
Journal:  Jpn J Cancer Res       Date:  1987-04

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

6.  Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.

Authors:  Nicolas Wentzensen; Elizabeth M Poole; Britton Trabert; Emily White; Alan A Arslan; Alpa V Patel; V Wendy Setiawan; Kala Visvanathan; Elisabete Weiderpass; Hans-Olov Adami; Amanda Black; Leslie Bernstein; Louise A Brinton; Julie Buring; Lesley M Butler; Saioa Chamosa; Tess V Clendenen; Laure Dossus; Renee Fortner; Susan M Gapstur; Mia M Gaudet; Inger T Gram; Patricia Hartge; Judith Hoffman-Bolton; Annika Idahl; Michael Jones; Rudolf Kaaks; Victoria Kirsh; Woon-Puay Koh; James V Lacey; I-Min Lee; Eva Lundin; Melissa A Merritt; N Charlotte Onland-Moret; Ulrike Peters; Jenny N Poynter; Sabina Rinaldi; Kim Robien; Thomas Rohan; Dale P Sandler; Catherine Schairer; Leo J Schouten; Louise K Sjöholm; Sabina Sieri; Anthony Swerdlow; Anna Tjonneland; Ruth Travis; Antonia Trichopoulou; Piet A van den Brandt; Lynne Wilkens; Alicja Wolk; Hannah P Yang; Anne Zeleniuch-Jacquotte; Shelley S Tworoger
Journal:  J Clin Oncol       Date:  2016-06-20       Impact factor: 44.544

7.  Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.

Authors:  M P Coleman; D Forman; H Bryant; J Butler; B Rachet; C Maringe; U Nur; E Tracey; M Coory; J Hatcher; C E McGahan; D Turner; L Marrett; M L Gjerstorff; T B Johannesen; J Adolfsson; M Lambe; G Lawrence; D Meechan; E J Morris; R Middleton; J Steward; M A Richards
Journal:  Lancet       Date:  2010-12-21       Impact factor: 79.321

8.  Ovarian cancer mortality among women aged 40-79 years in relation to reproductive factors and body mass index: latest evidence from the Japan Collaborative Cohort study.

Authors:  Md Mobarak Hossain Khan; Aklimunnessa Khan; Masahiro Nojima; Sadao Suzuki; Yoshihisa Fujino; Shinkan Tokudome; Koji Tamakoshi; Mitsuru Mori; Akiko Tamakoshi
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

9.  Trends in the use of oral contraceptives among adolescents and young women in Spain.

Authors:  Pilar Carrasco-Garrido; Ana López de Andrés; Valentín Hernández-Barrera; Isabel Jiménez-Trujillo; Mercedes Esteban-Peña; Napoleón Pérez-Farinós; Rodrigo Jiménez-García
Journal:  Reprod Health       Date:  2016-09-23       Impact factor: 3.223

10.  Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.

Authors:  Lisa Iversen; Shona Fielding; Øjvind Lidegaard; Lina S Mørch; Charlotte W Skovlund; Philip C Hannaford
Journal:  BMJ       Date:  2018-09-26
View more
  14 in total

1.  Update on cancer incidence trends in Canada, 1984 to 2017.

Authors:  Alain A Demers; Nathalie Saint-Jacques; Larry Ellison; Darren Brenner; Natalie Fitzgerald; Samina Aziz; Donna Turner
Journal:  Health Promot Chronic Dis Prev Can       Date:  2022-07       Impact factor: 2.725

Review 2.  Revisiting chemoresistance in ovarian cancer: Mechanism, biomarkers, and precision medicine.

Authors:  Chong Guo; Chaoying Song; Jiali Zhang; Yisong Gao; Yuying Qi; Zongyao Zhao; Chengfu Yuan
Journal:  Genes Dis       Date:  2020-12-01

3.  Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I.

Authors:  Andrea Esposito; Alessandra Ferraresi; Amreen Salwa; Chiara Vidoni; Danny N Dhanasekaran; Ciro Isidoro
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

4.  Joint IARC/NCI International Cancer Seminar Series Report: expert consensus on future directions for ovarian carcinoma research.

Authors:  Shama Virani; Glauco Baiocchi; David Bowtell; Citadel J Cabasag; Kathleen R Cho; Renée T Fortner; Keiichi Fujiwara; Jae-Weon Kim; Martin Köbel; Jean-Emmanuel Kurtz; Douglas A Levine; Usha Menon; Barbara M Norquist; Paul D P Pharoah; Anil K Sood; Shelley T Tworoger; Nicolas Wentzensen; Stephen J Chanock; Paul Brennan; Britton Trabert
Journal:  Carcinogenesis       Date:  2021-06-21       Impact factor: 4.944

5.  Clear differences in ovarian cancer incidence and trends by ethnicity among Asian Americans.

Authors:  Alice W Lee; Emma E Navajas; Lihua Liu
Journal:  Cancer Epidemiol       Date:  2019-06-26       Impact factor: 2.890

Review 6.  Plant-Derived Chinese Medicine Monomers on Ovarian Cancer via the Wnt/β-Catenin Signaling Pathway: Review of Mechanisms and Prospects.

Authors:  Jia-Yue Xu; Fang-Yuan Liu; Shao-Xuan Liu; Liang-Zhen Xie; Jia Li; Yu-Ting Ma; Feng-Juan Han
Journal:  J Oncol       Date:  2021-12-06       Impact factor: 4.375

7.  Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age-Period-Cohort Modelling.

Authors:  Paula Peremiquel-Trillas; Jon Frias-Gomez; Laia Alemany; Alberto Ameijide; Mireia Vilardell; Rafael Marcos-Gragera; Sònia Paytubi; Jordi Ponce; José Manuel Martínez; Marta Pineda; Joan Brunet; Xavier Matías-Guiu; Marià Carulla; Jaume Galceran; Ángel Izquierdo; Josep M Borràs; Laura Costas; Ramon Clèries
Journal:  Int J Environ Res Public Health       Date:  2022-01-27       Impact factor: 3.390

8.  Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study.

Authors:  Ming Yi; Tianye Li; Mengke Niu; Suxia Luo; Qian Chu; Kongming Wu
Journal:  Biomark Res       Date:  2021-07-07

Review 9.  Screening and Prevention for High-Grade Serous Carcinoma of the Ovary Based on Carcinogenesis-Fallopian Tube- and Ovarian-Derived Tumors and Incessant Retrograde Bleeding.

Authors:  Isao Otsuka; Takuto Matsuura
Journal:  Diagnostics (Basel)       Date:  2020-02-22

10.  Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma.

Authors:  Zhiwen Shi; Qingguo Zhao; Bin Lv; Xinyu Qu; Xiao Han; Hongyan Wang; Junjun Qiu; Keqin Hua
Journal:  Clin Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.